Clinical Trial Update: Ability of Curcumin to Decrease Cytokines Involved in Mucositis in the Autologous Transplant [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating curcumin's ability to decrease cytokines involved in oral mucositis in patients undergoing autologous transplant, completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Mucositis

Drugs mentioned

• Curcumin (curcumin)

Snippet

Sponsor: Tata Memorial Centre | Conditions: Oral Mucositis (Ulcerative) | Phase 2 | Status: COMPLETED